GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹7,955 Cr | ₹9,508 Cr | ₹8,175 Cr | ₹7,300 Cr | ₹6,391 Cr |
What is the latest Appropriations of GLENMARK PHARMACEUTICALS ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹7,955 Cr |
| Mar2024 | ₹9,508 Cr |
| Mar2023 | ₹8,175 Cr |
| Mar2022 | ₹7,300 Cr |
| Mar2021 | ₹6,391 Cr |
How is Appropriations of GLENMARK PHARMACEUTICALS Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,955 Cr | -16.33 | |
| Mar2024 | ₹9,508 Cr | 16.30 | |
| Mar2023 | ₹8,175 Cr | 12.00 | |
| Mar2022 | ₹7,300 Cr | 14.22 | |
| Mar2021 | ₹6,391 Cr | - | |
Compare Appropriations of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹64,405.1 Cr | 2.5% | 2.6% | 25.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 2.5% |
2.6% |
25.6% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses